Associations

From Satisfaction To Delight...
Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India
News Featured

Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India

Bringing a First-in-Class MBL Inhibitor to India: Venus Remedies Licenses MET-X Venus Remedies has taken a significant step in combating Antimicrobial Resistance (AMR) by securing exclusive licensing rights for MET-X, an innovative anti-bacterial drug from UK-based Infex Therapeutics. This landmark partnership will enable Venus Remedies to develop, gain regulatory approvals,
2 min read
image image image image image